Donate to HSC
Donate to HSC
Facebook
Twitter
Instagram

FDA APPROVES GENENTECH’S HEMLIBRA

® (EMICIZUMAB-KXWH) FOR HEMOPHILIA A WITH INHIBITORS – First new medicine in nearly 20 years to treat people with hemophilia A with inhibitors – – HEMLIBRA substantially reduced bleeds in adults and children – – Only medicine that can be self-administered once weekly...